Illumina & Nashville Biosciences ink sequencing agreement with Amgen

Fjölmiðlar

Tímabil	11 jan. 2023

Fjölmiðlaumfjöllun

Titill	Illumina & Nashville Biosciences ink sequencing agreement with Amgen
Heiti/miðill fjölmiðla	PharmaBiz
Land/Yfirráðasvæði	Indland
Dagsetning	11/01/23
URL	ct.moreover.com/?a=49718698790&p=1gw&v=1&x=NJCJj9dTLw2GWU5efOZZoA
Aðilar	Kári Stefánsson